Inpatient Biophysical Profiles and the Effect on Clinical Decision MakingFunding None.
Objective Our primary objective was to determine whether biophysical profiles (BPP) performed on the antepartum unit result in changes in clinical decision making.
Study Design A retrospective cohort chart review was performed among women who had a BPP during hospital admission. BPP status was categorized as normal (8/8 points) and abnormal (6/8 or less points). The primary outcome, clinical decision making, was the need for prolonged external fetal monitoring (defined as > 2 hours) or decision to proceed with delivery. Secondary outcomes included mode of delivery, indicated preterm delivery, birth weight, 5-minute Apgar's score <7, and neonatal intensive care unit (NICU) admission.
Results Among our cohort (n = 186), 85.5% (n = 159) had a normal BPP. Delivery management was altered in one case (0.54%) by the BPP findings, and there were no BPPs that resulted in need for prolonged monitoring. Compared with women with normal BPP, women with abnormal BPPs were more likely to deliver at <37 weeks, to be admitted to the NICU, or have a 5-minute Apgar's score <7.
Conclusion In-hospital BPPs alter clinical decision making in less than 1% of cases.
D.A.R. wrote the manuscript. D.A.R. and N.A. extracted and analyzed the data. K.H. and C.S. assisted with data input. H.Y.C. performed statistical analyses. S.P.C., S.B., B.S., and J.R. guided experimental design and researched data. All coauthors reviewed/edited the manuscript and contributed to the discussion.
Presented at a Meeting
Poster session (poster no.: 23 B) presented at 2018 ACOG Annual Clinical & Scientific Meeting, April 27–30, 2018, Austin, TX.
Received: 22 January 2020
Accepted: 15 March 2020
12 October 2020 (online)
© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.
- 1 Yoon BH, Romero R, Roh CR. et al. Relationship between the fetal biophysical profile score, umbilical artery Doppler velocimetry, and fetal blood acid-base status determined by cordocentesis. Am J Obstet Gynecol 1993; 169 (06) 1586-1594
- 2 Boekkooi PF, Baan Jr. J, Teitel D, Rudolph AM. Chemoreceptor responsiveness in fetal sheep. Am J Physiol 1992; 263 (1, Pt 2): H162-H167
- 3 Koos BJ, Sameshima H, Power GG. Fetal breathing, sleep state, and cardiovascular responses to graded hypoxia in sheep. J Appl Physiol (1985) 1987; 62 (03) 1033-1039
- 4 Manning FA, Platt LD, Sipos L. Antepartum fetal evaluation: development of a fetal biophysical profile. Am J Obstet Gynecol 1980; 136 (06) 787-795
- 5 Manning FA, Baskett TF, Morrison I, Lange I. Fetal biophysical profile scoring: a prospective study in 1,184 high-risk patients. Am J Obstet Gynecol 1981; 140 (03) 289-294
- 6 Natale R, Clewlow F, Dawes GS. Measurement of fetal forelimb movements in the lamb in utero. Am J Obstet Gynecol 1981; 140 (05) 545-551
- 7 Manning FA, Harman CR, Morrison I, Menticoglou S. Fetal assessment based on fetal biophysical profile scoring. IV. An analysis of perinatal morbidity and mortality. Am J Obstet Gynecol 1990; 162 (02) 398-402
- 8 Manning FA, Harman CR, Morrison I, Menticoglou SM, Lange IR, Johnson JM. Fetal assessment based on fetal biophysical profile scoring. IV. An analysis of perinatal morbidity and mortality. Am J Obstet Gynecol 1990; 162 (03) 703-709
- 9 Manning FA, Snijders R, Harman CR, Nicolaides K, Menticoglou S, Morrison I. Fetal biophysical profile score. VI. Correlation with antepartum umbilical venous fetal pH. Am J Obstet Gynecol 1993; 169 (04) 755-763
- 10 Manning FA. Antepartum fetal testing: a critical appraisal. Curr Opin Obstet Gynecol 2009; 21 (04) 348-352
- 11 Clark SL, Sabey P, Jolley K. Nonstress testing with acoustic stimulation and amniotic fluid volume assessment: 5973 tests without unexpected fetal death. Am J Obstet Gynecol 1989; 160 (03) 694-697
- 12 Miller DA, Rabello YA, Paul RH. The modified biophysical profile: antepartum testing in the 1990s. Am J Obstet Gynecol 1996; 174 (03) 812-817
- 13 Nageotte MP, Towers CV, Asrat T, Freeman RK. Perinatal outcome with the modified biophysical profile. Am J Obstet Gynecol 1994; 170 (06) 1672-1676
- 14 American College of Obstetricians and Gynecologists. Committee on practice bulletins. Antepartum fetal surveillance. ACOG practice bulletin no. 145. Obstet Gynecol 2014; 124 (01) 182-192
- 15 Duryea EL, Hawkins JS, McIntire DD, Casey BM, Leveno KJ. A revised birth weight reference for the United States. Obstet Gynecol 2014; 124 (01) 16-22
- 16 Lewis DF, Adair CD, Weeks JW, Barrilleaux PS, Edwards MS, Garite TJ. A randomized clinical trial of daily nonstress testing versus biophysical profile in the management of preterm premature rupture of membranes. Am J Obstet Gynecol 1999; 181 (06) 1495-1499